Protagonist Therapeutics (PTGX) Shares Issued (2016 - 2026)

Protagonist Therapeutics has disclosed Shares Issued across 11 years of filings, most recently posting $23.4 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $23.4 million, up 96.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.8 million (up 13.8% YoY), and the FY2025 annual result was $23.3 million, down 11.76% from the prior year.
• Shares Issued came in at $23.4 million for Q1 2026 at Protagonist Therapeutics, up from $2.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $104.6 million in Q3 2023 to a low of -$104.6 million in Q2 2023.
• The 5-year median for Shares Issued is $2.8 million (2025), against an average of $4.7 million.
• Across the five-year window, Shares Issued slumped 16064.27% in 2023 and soared 50287.5% in 2024, its largest moves.
• Protagonist Therapeutics' Shares Issued stood at $553000.0 in 2022, then plunged by 98.55% to $8000.0 in 2023, then jumped by 50287.5% to $4.0 million in 2024, then fell by 29.62% to $2.8 million in 2025, then soared by 723.9% to $23.4 million in 2026.
• The last three Shares Issued figures came in at $23.4 million (Q1 2026), $2.8 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.